3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
15
Phase 4
3
Phase EARLY_PHASE1
2
Phase 1
2
Phase 2
1
Phase 1/2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Conditions
Colorectal Neoplasms
752
Pancreatic Neoplasms
665
Stomach Neoplasms
387
Carcinoma, Non-Small-Cell Lung
376
Carcinoma, Hepatocellular
368
Breast Neoplasms
316
Colonic Neoplasms
279
Ovarian Neoplasms
260
Neoplasms
250
Esophageal Neoplasms
237
Neoplasm Metastasis
215
Rectal Neoplasms
202
Melanoma
195
Lung Neoplasms
193
Liver Neoplasms
180
Squamous Cell Carcinoma of Head and Neck
150
Carcinoma, Renal Cell
146
Head and Neck Neoplasms
124
Prostatic Neoplasms
123
Triple Negative Breast Neoplasms
110
Uterine Cervical Neoplasms
106
Urinary Bladder Neoplasms
106
Cholangiocarcinoma
104
Endometrial Neoplasms
101
Sarcoma
100
Small Cell Lung Carcinoma
74
Gastrointestinal Neoplasms
73
Esophageal Squamous Cell Carcinoma
68
Kidney Neoplasms
63
Carcinoma, Transitional Cell
60
Interventions
palbociclib
2
Rivaroxaban
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Inflammation
×
Gastrointestinal
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled